*AstraZeneca, Pfizer, UK charity link in multi-drug trial. Instead of testing one drug at a time, a novel lung cancer study announced on Thursday will allow British researchers to test up to 14 drugs from AstraZeneca and Pfizer at the same time within one trial.» Read More
ZURICH, April 15- A strong uptake of new cancer medicines helped Roche to limit a decline in first-quarter sales and the Swiss company confirmed a forecast for higher earnings this year.
*Q1 sales 11.496 bln Swiss francs vs 11.887 bln forecast. ZURICH, April 15- Adverse currency moves weighed on first-quarter sales at Roche Holding AG, which fell 1 percent, despite a healthy uptake of its new cancer medicines.
Google Glass might have another purpose than just entertaining. Dr Horng from Boston said that it helped saved a patient's life last January.
NEW YORK, April 14- There are many enterprises out there trying to separate you from your tax refund- from splurges such as airlines tickets for a celebratory vacation or for good purposes, like putting it all in a college savings account.
Dr. Steven Horng, Beth Israel Deaconess Medical Center, explains how Google Glass provided crucial support in an emergency situation and helped save a life.
April 14- Lexicon Pharmaceuticals Inc said its experimental drug to treat diabetes met the main goal of reducing the use of insulin at meal times in a mid-stage study on patients with type 1 diabetes. The company's shares rose 19.5 percent to $1.90 in trading before the bell.
April 14- Lexicon Pharmaceuticals Inc said its experimental drug to treat diabetes met the main goal of reducing the use of insulin at meal times in a mid-stage study on patients with type 1 diabetes. The company's shares rose about 19 percent to $1.89 in trading before the bell.
April 12- A drug being developed by Intercept Pharmaceuticals Inc led to significant improvement in signs of a rare liver disease that primarily affects middle-aged women, likely reducing the risk of need for liver transplant and of death, according to results of a late-stage clinical trial presented on Saturday.
LOS ANGELES/ LONDON April 11- Doctors at a key medical conference welcomed the prospect of more new drugs to treat the liver-destroying hepatitis C virus, while agreeing that Gilead Sciences Inc continues to lead the effort.
MEXICO CITY— Police in Mexico City have issued a warning about a new type of "ransom ware" virus that can take over computers' cameras and make the user think they are under surveillance. The Mexico City police department's cyber-crime unit says the virus infects computers, generally after they view or download sexually explicit material.
CNBC contributor Barbara Ryan provides insight into new guidelines from the World Health Organization, which strongly endorses two new hepatitis c drugs.
WASHINGTON, April 10- The leading U.S. pharmaceutical industry trade group on Thursday defended the cost of Gilead Sciences Inc's new hepatitis C drug, Sovaldi, saying such treatments offer a priceless breakthrough for patients with the liver-destroying virus.
PORTLAND, Maine— Maine's severe restrictions on opioid painkillers for Medicaid patients, requiring many to instead seek alternative pain management treatment for the past year, have sharply reduced the number of people obtaining highly addictive medications blamed for drug abuse and deaths around the nation.
MUMBAI, April 10- India's Natco Pharma Ltd has formally asked the Indian patent office to deny U.S. drugmaker Gilead Sciences Inc's new hepatitis C drug Sovaldi a patent in India, a source with direct knowledge of the matter said.
CNBC's Jim Cramer speaks with Robert Hugin, Celgene chairman & CEO, about America's need to build a stronger and more sustainable ecosystem of innovation to continue as the world leader in biomedical innovation.
April 10- Biogen Idec Inc and Swedish Orphan Biovitrum said their experimental blood disorder drug was effective in treating children with hemophilia in a late-stage trial.
April 10- A combination of two anti-viral drugs developed by Bristol-Myers Squibb Co cured 90 percent of previously untreated hepatitis C patients and 82 percent of those who failed to respond to prior therapy, according to results from a late stage study presented on Thursday.
April 10- A two-drug combination being tested by Merck& Co to treat hepatitis C cured 98 percent of previously untreated patients without cirrhosis in a midstage clinical trial, providing the latest evidence that the U.S. drugmaker will be highly competitive in the fast evolving field.
A new virus has killed millions of baby pigs in the U.S. in less than a year. The consequence? Bacon prices rising by more than ten percent.
April 9- Halozyme Therapeutics Inc said the U.S. Food and Drug Administration ordered a halt on a study of its drug delivery system in pancreatic cancer patients, barely a week after the company voluntarily stopped the trial. The company's shares fell about 3 percent to $8.06 in trading before the bell.